🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Phase 1b

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors NCT07222267Phase 132 sites📍 Birmingham📍 New Haven📍 St Louis BeOne Medicines · Tests: BG-75202, CDK4 Inhibitor, Estrogen Receptor Antagonist, Aromatase Inhibitor A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients NCT07303660Phase 16 sites📍 Moscow📍 Krasnogorsk📍 Velikiy Novgorod Lomond Therapeutics Holdings, Inc. · Tests: ZE50-0134, Azacitidine Days 1-7, ZE 50-0134 A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity NCT07291232Phase 12 sites📍 Anaheim📍 Grayslake AbbVie · Tests: ABBV-295, Placebo A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy NCT07633756Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: REC617 ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC NCT06816992Phase 14 sites📍 New York📍 Fairfax📍 Melbourne ORIC Pharmaceuticals · Tests: ORIC-114 Dose 1 + amivantamab, ORIC-114 Dose 2 + amivantamab, ORIC-114 Dose 3 + amivantamab A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma NCT06753747Phase 1, Phase 21 site📍 Chengdu West China Hospital · Tests: Palbociclib, Afatinib(30mg), Afatinib(40mg), Afatinib(RP2D) A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma NCT04973605Phase 1, Phase 274 sites📍 Birmingham📍 Duarte📍 Irvine BeOne Medicines · Tests: Sonrotoclax, Dexamethasone, Carfilzomib, Daratumumab, Pomalidomide AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors NCT07094113Phase 139 sites📍 Duarte📍 Los Angeles📍 Atlanta Amgen · Tests: AMG 410, Pembrolizumab, Panitumumab A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients NCT06249919Phase 1, Phase 216 sites📍 Bucheon-si📍 Gwangju📍 Ilsan Neuracle Science Co., LTD. · Tests: NS101, Placebo 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer NCT07145177Phase 11 site📍 San Francisco University of California, San Francisco · Tests: 177Lu-PSMA-617, Ablation, Trans-arterial chemoembolization (TACE), Positron Emission Tomography (PET)/Computerized tomo… Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer NCT05172245Phase 118 sites📍 Tampa📍 Chicago📍 Fairway National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Cisplatin, Computed Tomography, Ipatasertib Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma NCT07136181Phase 1, Phase 23 sites📍 Scottsdale📍 Denver📍 Nashville Novelwise Pharmaceutical Corporation · Tests: NBM-BMX Capsule are proprietary products developed by Novelwise Pharmaceutical Corporation (Novelwise) for treatment of… A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures NCT07233239Phase 124 sites📍 Phoenix📍 La Jolla📍 New Haven Jazz Pharmaceuticals · Tests: CBD-OS Efficacy and Safety of Ivonescimab Plus Pemetrexed and Platinum-Based Chemotherapy in Advanced Malignant Pleural Mesothelioma NCT07885319Phase 1, Phase 23 sites📍 Shanghai📍 Shanghai📍 Chengdu Ruijin Hospital · Tests: Ivonescimab Combined With Chemotherapy A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2 NCT06240728Phase 18 sites📍 Baltimore📍 Boston📍 The Bronx NextPoint Therapeutics, Inc. · Tests: NPX887 PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas NCT06961565Phase 15 sites📍 Birmingham📍 St Leonards📍 Melbourne Pasithea Therapeutics Corp. · Tests: PAS-004 Tablets A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer NCT05365581Phase 146 sites📍 Orange📍 Santa Monica📍 Chicago Astellas Pharma Global Development, Inc. · Tests: ASP2138, Pembrolizumab, Oxaliplatin, Leucovorin, Fluorouracil The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer NCT07204574Phase 1, Phase 21 site📍 Taoyuan Chang Gung Memorial Hospital · Tests: HCB101, Bevacizumab, Cetuximab (Erbitux), FOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan), FOLFOX (Oxaliplatin/Le… A Phase 1 Open-Label Study of the Safety of Intravenous Allogeneic Neonatal Mesenchymal Cells (nMSCs) in Young Adult (1A) and Pediatric (1B) Patients With Dilated Cardiomyopathy (DCM) NCT06464588Phase 15 sites📍 Atlanta📍 Atlanta📍 Atlanta Emory University · Tests: Allogeneic Neonatal mesenchymal stromal cells (nMSCs) A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 NCT07292168Phase 1, Phase 25 sites📍 Kazan'📍 Krasnoyarsk📍 Moscow Kidney Cancer Research Bureau · Tests: humanized monoclonal anti-FGFR1 antibody OM-RCA-01 Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor NCT05508009Phase 1, Phase 21 site📍 Palo Alto Alice Bertaina · Tests: Cyclophosphamide 1200 mg/Kg, Fludarabine, Cyclophosphamide 100 mg/Kg, Total Body Irradiation, ATG Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial NCT04693468Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Axitinib, Crizotinib, Palbociclib Isethionate, Talazoparib Tosylate A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003). NCT06843447Phase 1, Phase 239 sites📍 New Haven📍 Louisville📍 Shreveport Merck Sharp & Dohme LLC · Tests: Raludotatug Deruxtecan, Carboplatin, Paclitaxel, Bevacizumab, Rescue Medication Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis NCT06934252Phase 119 sites📍 Belconnen📍 Albion📍 Blacktown TRex Bio, Inc. · Tests: TRB-061, TRB-061, TRB-061, Placebo CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites📍 Denver📍 Chicago📍 Grand Rapids Context Therapeutics Inc. · Tests: CT-95 A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors NCT07361562Phase 115 sites📍 Scottsdale📍 Scottsdale📍 New Haven Cogent Biosciences, Inc. · Tests: CGT4255 Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations NCT06772623Phase 1, Phase 2126 sites📍 Phoenix📍 Fullerton📍 Oxnard AbbVie · Tests: Telisotuzumab Adizutecan, Budigalimab, Pembrolizumab, Pembrolizumab, Carboplatin A Phase 1b/2 Study of Ropeginterferon Alfa-2b Added to Azacitidine in MDS/AML With TP53 Mutations NCT07646821Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: ropeginterferon alfa- 2b, Azacitidine (AZA) Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali. NCT07758985Phase 11 site📍 Bamako Medicines for Malaria Venture · Tests: Cohort 1 low dose lotilaner with a high-fat meal, Cohort 1 low dose placebo with a high-fat meal, Cohort 2 high dose lo… TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer NCT06868433Phase 12 sites📍 Atlanta📍 Atlanta Emory University · Tests: Autologous Tumor Membrane Vesicles Vaccine, Biospecimen Collection, Computed Tomography, Echocardiography, Magnetic Res…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy